European Heart Journal Advance Access published online on June 7, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi341
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Cardiology, University of Padua Medical School, Padova, Italy
* To whom correspondence should be addressed. Aims To characterize the clinical profile of patients belonging to families affected with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) due to mutations of the gene encoding for the cell-to-cell adhesion protein desmoplakin (DSP). Methods and results Thirty-eight subjects belonging to four families showing different DSP mutations (three missense and one in the intron-exon splicing region) underwent clinical and genetic investigation, including annual 12-lead ECG, signal averaged ECG, 24 h Holter ECG, and two-dimensional echocardiography. Twenty-six family members (11 males and 15 females) were found to carry a DSP mutation. After a follow-up of 1-24 years, median 6, 14 (54%) fulfilled (mean age at diagnosis 33±15 years) and 12 (mean age 43±24 years at the last follow-up) did not fulfil the established diagnostic criteria of ARVC, although five of them had some cardiac abnormalities. Clinical presentations were palpitations in six, sudden death (SD) in three, syncope in one, and chest pain with increased myocardial enzymes in two. Abnormal 12-lead ECG findings were present in 15 cases (58%), ventricular arrhythmias in 12 (46%), and late potentials in 11 (42%). Fourteen (54%) had abnormal echocardiographic findings, with left ventricular involvement in seven of them. SD occurred in six subjects and in three it was the first symptom of the disease; moreover, one subject died due to heart failure. The annual disease-related death and SD/aborted SD were 0.028 and 0.023 patient/year, respectively. Conclusion Familial ARVC caused by DSP mutations is characterized by a high occurrence of SD even as first clinical manifestation. Left ventricular involvement is not a rare feature of the disease, which frequently escapes clinical diagnosis by applying the currently available criteria. Genetic screening is mandatory for early identification of asymptomatic carriers and preventive strategies within a family with a genotyped index case.
Received November 3, 2004
Revised April 22, 2005
Accepted April 28, 2005
Clinical research
Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations
2 Institute of Pathology, University of Padua Medical School, Padova, Italy
3 Department of Biology, University of Padua, Padova, Italy
4 Department of Biochemistry and Pharmacy, Abo Akademi University, Turku, Finland
5
Institute of Pathology, University of Padua Medical School, Padova, Italy
Gaetano Thiene, E-mail: cardpath{at}unipd.it
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. A. Bhuiyan, J. D.H. Jongbloed, J. van der Smagt, P. M. Lombardi, A. C.P. Wiesfeld, M. Nelen, M. Schouten, R. Jongbloed, M. G.P.J. Cox, M. van Wolferen, et al. Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients: Results From a Multicenter Study Circ Cardiovasc Genet, October 1, 2009; 2(5): 418 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jain, D. Dalal, A. Daly, C. Tichnell, C. James, A. Evenson, R. Jain, T. Abraham, B. Y. Tan, H. Tandri, et al. Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia Circulation, August 11, 2009; 120(6): 477 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pilichou, C. A. Remme, C. Basso, M. E. Campian, S. Rizzo, P. Barnett, B. P. Scicluna, B. Bauce, M. J.B. van den Hoff, J. M.T. de Bakker, et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy J. Exp. Med., August 3, 2009; 206(8): 1787 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lombardi, J. Dong, G. Rodriguez, A. Bell, T. K. Leung, R. J. Schwartz, J. T. Willerson, R. Brugada, and A. J. Marian Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy Circ. Res., May 8, 2009; 104(9): 1076 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1289 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, S. K. Prasad, S. E. Hughes, R. Merrifield, D. Ward, D. J. Pennell, and W. J. McKenna Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2175 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Basso, F. Ronco, F. Marcus, A. Abudureheman, S. Rizzo, A. C. Frigo, B. Bauce, F. Maddalena, A. Nava, D. Corrado, et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria Eur. Heart J., November 2, 2008; 29(22): 2760 - 2771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al. Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L.P. Caforio, F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis Eur. Heart J., June 1, 2007; 28(11): 1326 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, D. Ward, A. Asimaki, E. Sevdalis, and W. J. McKenna Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression Circulation, April 3, 2007; 115(13): 1710 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Syrris, D. Ward, A. Asimaki, A. Evans, S. Sen-Chowdhry, S. E. Hughes, and W. J. McKenna Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease Eur. Heart J., March 1, 2007; 28(5): 581 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vatta, F. Marcus, and J. A. Towbin Arrhythmogenic right ventricular cardiomyopathy: a 'final common pathway' that defines clinical phenotype Eur. Heart J., March 1, 2007; 28(5): 529 - 530. [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, S. K. Prasad, P. Syrris, R. Wage, D. Ward, R. Merrifield, G. C. Smith, D. N. Firmin, D. J. Pennell, and W. J. McKenna Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited: Comparison With Task Force Criteria and Genotype J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2132 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, L. H. Molin, J. Piccini, C. Tichnell, C. James, C. Bomma, K. Prakasa, J. A. Towbin, F. I. Marcus, P. J. Spevak, et al. Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2 Circulation, April 4, 2006; 113(13): 1641 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pilichou, A. Nava, C. Basso, G. Beffagna, B. Bauce, A. Lorenzon, G. Frigo, A. Vettori, M. Valente, J. Towbin, et al. Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Circulation, March 7, 2006; 113(9): 1171 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Basso, G. Thiene, A. Nava, G. H. Fontaine, P. Fornes, S. Sen-Chowdhry, P. Syrris, W. J. McKenna, M. Norman, J. Mogensen, et al. Letter Regarding Article by Norman et al, "Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy" * Response Circulation, February 7, 2006; 113(5): e68 - e69. [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies Eur. Heart J., August 2, 2005; 26(16): 1582 - 1584. [Full Text] [PDF]
|
|